[Abstract] [Full Text PDF] (in Japanese / 2128KB) [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 81(9): 1151-1154, 1980


Report on the annual meeting

EFFECT OF HYPERALIMENTATION ON CANCER THERAPY AND CELLULAR IMMUNITY IN CANCER PATIENTS

Department of Surgery, University of Niigata School of Medicine, Niigata, Japan
*) Department of Surgery, Shinrakuen Hospital, Niigata, Japan

Y. Matsubara, Y. Ohsawa, M. Tsutsui, H. Takahashi, A. Maruyama, M. Kawaguchi, R. Oyanagi, M. Iwafuchi, T. Shimizu*), T. Muto

For this study, 55 patients were selected to evaluate the hyperalimentation in cancer therapy, who had carcinoma of esophagus (27), stomach (12), pancreas (2) or gallbladder (1), neuroblastoma (7), Wilms tumor (3), hepatoblastoma (2) or malignant teratoma (1). They received nutritional support of 40 to 60 Cal/kg/day with intravenous hyperalimentation or elemental diet, and were treated with radiation therapy, chemotherapy or both for two weeks to four months. Most of them could complete their planned course of the cancer therapy. Many of them who improved their nutritional repletion and gained weight of one to seven Kg, responded to the therapy and had increase of T cell count in lymphocytes, although they did not develop or retaine positive skin test reactivity. It will be possible that proper nutritional repletion by means of hyperalimentation in cancer patients who received radiation therapy or chemotherapy, can restored cellular immunity.


<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.